In SeekingAlpha Biotech Stocks - Posted 6 days ago

As one of six products that the European regulator recommended for approval last Friday, Johnson & Johnson s (JNJ) new psoriasis treatment Stelara (...

Tags: pharma

In SeekingAlpha Biotech Stocks - Posted 1 week ago

Achillion Pharma (ACHN) is a promising micro-cap biotech, specializing in the development of new treatments for infectious diseases, such as the multi...

Tags: biotech pharma

In SeekingAlpha Biotech Stocks - Posted 1 week ago

Last week in China biotech, the flood of quarterly earnings reports slowed from the previous week s frenetic pace, and normal business news fina...

Tags: biotech pharma

In SeekingAlpha Biotech Stocks - Posted 1 week ago

The fear and pessimism behind major selling pressure and stock market losses can be summarized by the late Jim Morrison in a song by The Doors called ...

Tags: clinical trial pharma

In SeekingAlpha ETFs - Posted 2 weeks ago

Buying at lower levels in the index heavyweights pulled the indices off their lows during the final hours of trade. Select stocks from software, energ...

Tags: bse india lows markets nse nse nifty pharma sensex trading

In SeekingAlpha Biotech Stocks - Posted 2 weeks ago

Generally in micro cap biotech investing, one encounters the classic all or none proposition: either the science works and the company flourishes or...

Tags: biotech pharma vc

In SeekingAlpha ETFs - Posted 2 weeks ago

Generally in micro cap biotech investing, one encounters the classic all or none proposition: either the science works and the company flourishes or...

Tags: biotech pharma pipeline tax

In SeekingAlpha ETFs - Posted 2 weeks ago

Shengtai Pharmaceutical, Inc. (SGTI.OB) reported that the August Olympics caused a slowdown in its fiscal year 2009 Q1 (ended September 30, 2008) fina...

Tags: beijing pharma

In Health Business Blog - Posted 2 weeks ago

Big pharma has big problems. The root cause is a lack of R&D productivity, which means a dearth of new products to make up for looming patent expirati...

Tags: health pharma

In SeekingAlpha ETFs - Posted 2 weeks ago

Earlier this week BioSante Pharma (BPAX) reported 3Q08 results which included a net loss of $6.6M or ($0.24) per share and a loss of $16.3M or ($0.60)...

Tags: pharma phase

Featured Investment Blogs